pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 2
    panobacumab
    Aerumab (panobacumab [INN])
    Hospital Acquired Pneumonia (HAP) Aridis Pharmaceuticals Inc
  • Marketed
    parathyroid hormone
    Natpara (parathyroid hormone)
    Hypoparathyroidism Takeda Pharmaceuticals America Inc
  • Marketed
    paricalcitol
    Paricalcitol
    Secondary Hyperparathyroidism Marksans Pharma Inc
  • Phase 3
← prev
page 204 of 231
next →
Pain89
Neurology1
paridiprubart
paridiprubart
Coronavirus Disease 2019 (COVID-19) Associated Acute Resp…
$EDSA Edesa Biotech, Inc.
  • pre_registration
    pariglasgene brecaparvovec
    pariglasgene brecaparvovec
    Glycogen Storage Disease 1A$RARE Ultragenyx Pharmaceutical Inc.
  • Phase 3
    paromomycin
    Paromomycin Sulfate (paromomycin [INN])
    Leishmaniasis Appili Therapeutics Inc
  • Marketed
    paroxetine mesylate
    Brisdelle (paroxetine mesylate)
    Vasomotor Symptoms of Menopause (Hot Flashes) Legacy Pharma Solutions
  • Marketed
    pasireotide
    Signifor (pasireotide)
    Pituitary ACTH Hypersecretion (Cushing Disease) Recordati Corp
  • Phase 3
    pasritamig
    pasritamig
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$JNJ JOHNSON & JOHNSON
  • Phase 3
    patidegib hydrochloride
    patidegib hydrochloride
    Gorlin Syndrome (Basal Cell Nevus Syndrome/ Nevoid Basal…$SLGL Sol-Gel Technologies Ltd.
  • Marketed
    patiromer sorbitex calcium
    Veltassa (patiromer sorbitex calcium)
    Hyperkalemia Vifor Pharma Inc
  • Marketed
    patisiran
    Onpattro (patisiran)
    Familial Amyloid Neuropathies$ALNY ALNYLAM PHARMACEUTICALS, INC.
  • Phase 3
    patritumab deruxtecan
    patritumab deruxtecan
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Daiichi Sankyo Co Ltd
  • Phase 3
    paxalisib
    paxalisib
    Recurrent Glioblastoma Multiforme (GBM)$KZIA KAZIA THERAPEUTICS LTD
  • Marketed
    pazopanib hydrochloride
    Pazopanib Hydrochloride
    Renal Cell Carcinoma Novugen Pharma (Malaysia) Sdn Bhd
  • Marketed
    peanut (Arachis hypogaea) allergen
    Palforzia
    Peanut Allergy Aimmune Therapeutics Inc
  • Phase 2
    peceleganan
    peceleganan [INN]
    Diabetic Foot Ulcers Jiangsu ProteLight Pharmaceutical And Biotechnology Co Ltd
  • pre_registration
    pegargiminase
    pegargiminase
    Malignant Pleural Mesothelioma$PII Polaris Inc.
  • Marketed
    pegaspargase
    Oncaspar (pegaspargase)
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Servier Pharmaceuticals LLC
  • Phase 2
    pegevongitide
    pegevongitide [INN]
    Coronavirus Disease 2019 (COVID-19) Pneumonia Vasomune Therapeutics Inc
  • Marketed
    pegfilgrastim
    Udenyca (pegfilgrastim-cbqv)
    Febrile Neutropenia Accord Biopharma Inc
  • Preclinical
    pegfilgrastim biosimilar
    Fylnetra (pegfilgrastim-pbbk)
    Unspecified Cancer Meitheal Pharmaceuticals Inc
  • Marketed
    peginterferon alfa-2a
    Pegasys (peginterferon alfa-2a)
    Hepatitis B pharmaand GmbH
  • Marketed
    peginterferon beta-1a
    Plegridy (peginterferon beta-1a)
    Progressive Relapsing Multiple Sclerosis (PRMS)$BIIB BIOGEN INC.
  • Phase 3
    peginterferon lambda-1a
    peginterferon lambda-1a
    Coronavirus Disease 2019 (COVID-19) Eiger Inno Therapeutics Inc
  • Marketed
    pegloticase
    Krystexxa (pegloticase)
    Gouty Arthritis (Gout) Horizon Therapeutics USA Inc
  • Phase 1
    pegmispotide
    pegmispotide[INN]
    Ulcerative Colitis Adiso Therapeutics Inc
  • Phase 3
    pegozafermin
    pegozafermin
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or… 89bio Inc
  • Phase 2
    pegsebrenatide
    pegsebrenatide [INN]
    Multiple Sclerosis Neuraly Inc
  • Phase 2
    pegtarazimod hydrochloride
    pegtarazimod hydrochloride
    Chronic Obstructive Pulmonary Disease (COPD) ReAlta Life Sciences Inc